June 26, 2017 4:58pm

BLUE closed down -$4.20 to $1.06.90 after Monday's -$0.90 or -0.80% to $111.10



bluebird bio (BLUE), has commenced an underwritten public offering of $350 million of its common stock.

BLUE also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering.


Goldman Sachs & Co. LLC, BofA Merrill Lynch and Cowen are acting as joint book-running managers of the proposed offering.


The Bottom Line: $105.00 a share for 35 M shares? 40.95 M shares outstanding with a float of 40.58 M shares ... and $634.07 M as of the end of Q1/17